ALC - Alcon AG - Stock Price & Dividends
Exchange: USA Stocks • Country: Switzerland • Currency: USD • Type: Common Stock • ISIN: CH0432492467
Contact Lenses, Surgical Instruments, Implantables, Vitamins, Eye Drops
Alcon AG is a global leader in the eye care industry, dedicated to improving vision and enhancing the quality of life for patients worldwide. The company's comprehensive portfolio of products and services is designed to support eye care professionals in providing the best possible care for their patients.
The Surgical segment of Alcon AG offers a wide range of innovative products and solutions for ophthalmic surgeons, including advanced equipment, instrumentation, and diagnostics. This includes intraocular lenses (IOLs), implantables, and consumables, such as viscoelastics and surgical solutions, designed to facilitate complex surgical procedures. The company's cataract products, such as the Centurion vision system and LenSx laser system, are designed to provide precise and efficient solutions for cataract removal and intraocular lens implantation. Additionally, Alcon AG offers a range of vitreoretinal products, including constellation vision systems, procedure packs, and medical grade vitreous tamponades, to support surgeons in treating complex retinal conditions.
Alcon AG's refractive surgery products, such as WaveLight lasers and Contoura Vision, are designed to provide precise and effective solutions for LASIK treatment. The company's implantable products, including AcrySof IQ products, offer advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Furthermore, Alcon AG's EX-PRESS glaucoma filtration device provides a minimally invasive solution for glaucoma treatment.
The Vision Care segment of Alcon AG provides a comprehensive range of products and solutions for patients, including daily disposable, reusable, and color-enhancing contact lenses. The company's ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies, are designed to promote healthy vision and alleviate common eye care issues. Additionally, Alcon AG offers ocular vitamins and redness relievers to support overall eye health.
With a rich history dating back to 1945, Alcon AG has established itself as a trusted partner for eye care professionals and patients worldwide. Headquartered in Geneva, Switzerland, the company continues to innovate and expand its product portfolio, driven by its commitment to improving vision and enhancing the quality of life for people around the world.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
ALC Stock Overview
Market Cap in USD | 48,515m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2019-04-09 |
ALC Stock Ratings
Growth 5y | 64.8 |
Fundamental | 54.1 |
Dividend | 43.4 |
Rel. Performance vs Sector | 0.97 |
Analysts | 4.29/5 |
Fair Price Momentum | 99.03 USD |
Fair Price DCF | 55.15 USD |
ALC Dividends
Dividend Yield 12m | 0.27% |
Yield on Cost 5y | 0.47% |
Dividends CAGR 5y | 4.02% |
Payout Consistency | 99.4% |
ALC Growth Ratios
Growth 12m | 28.66% |
Growth Correlation 12m | 95% |
Growth Correlation 3m | 92% |
CAGR 5y | 11.53% |
CAGR/Mean DD 5y | 1.13 |
Sharpe Ratio 12m | 0.98 |
Alpha vs SP500 12m | -10.07 |
Beta vs SP500 5y weekly | 1.12 |
ValueRay RSI | 33.49 |
Volatility GJR Garch 1y | 20.04% |
Price / SMA 50 | 1.48% |
Price / SMA 200 | 12.63% |
Current Volume | 464.1k |
Average Volume 20d | 685.5k |
External Links for ALC Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 05, 2024, the stock is trading at USD 97.27 with a total of 464,075 shares traded.
Over the past week, the price has changed by -2.38%, over one month by +2.96%, over three months by +8.74% and over the past year by +29.12%.
According to ValueRays Forecast Model, ALC Alcon AG will be worth about 109.6 in October 2025. The stock is currently trading at 97.27. This means that the stock has a potential upside of +12.71%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 101.5 | 4.35 |
Analysts Target Price | 93.3 | -4.08 |
ValueRay Target Price | 109.6 | 12.7 |